206 related articles for article (PubMed ID: 24496335)
1. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
Skitek M; Kranjec I; Jerin A
Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
3. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
Foroughinia F; Salamzadeh J; Namazi MH
Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
[TBL] [Abstract][Full Text] [Related]
4. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
[TBL] [Abstract][Full Text] [Related]
5. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
[TBL] [Abstract][Full Text] [Related]
6. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
[TBL] [Abstract][Full Text] [Related]
8. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
9. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
12. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
13. [Plasma levels of N-terminal pro-brain natriuretic peptide and glycogen phosphorylase isoenzyme BB in neonates with asphyxia complicated by myocardial injury].
Lin LX; Mao QH; Zhang ZL; An CX; Kang XG
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):252-5. PubMed ID: 20416213
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Cho KI; Kim BH; Je HG; Park YH
Catheter Cardiovasc Interv; 2013 May; 81(6):959-67. PubMed ID: 22744792
[TBL] [Abstract][Full Text] [Related]
15. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E
J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370
[TBL] [Abstract][Full Text] [Related]
17. Glycogen phosphorylase BB in acute coronary syndromes.
Peetz D; Post F; Schinzel H; Schweigert R; Schollmayer C; Steinbach K; Dati F; Noll F; Lackner KJ
Clin Chem Lab Med; 2005; 43(12):1351-8. PubMed ID: 16309372
[TBL] [Abstract][Full Text] [Related]
18. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
[TBL] [Abstract][Full Text] [Related]
19. Impact of the troponin standard on the prevalence of acute myocardial infarction.
Kontos MC; Fritz LM; Anderson FP; Tatum JL; Ornato JP; Jesse RL
Am Heart J; 2003 Sep; 146(3):446-52. PubMed ID: 12947361
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
